Mefquick DM 80mg/250mg Tablet
Marketer
Silhos Pharma Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Mefquick DM 80mg/250mg Tablet
Combiflam Relief 80mg/250mg tablets offer relief from abdominal pain. This combination medication effectively eases abdominal pain, bloating, discomfort, and cramping by relaxing stomach and intestinal muscles. It also inhibits pain-inducing chemical signals. Combiflam Relief 80mg/250mg tablets should be taken with food, following your doctor's prescribed dosage and duration. Dosage is tailored to individual needs and response. Continue treatment as directed; premature discontinuation may cause symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or tasks requiring concentration until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy planning, breastfeeding, and any kidney or liver conditions to your doctor before starting treatment to ensure appropriate dosage.
Primary Ingredients of Mefquick DM 80mg/250mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Mefquick DM 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Mefquick DM 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mefquick DM 80mg/250mg tablets should be administered with a meal.
Common Side effects of Mefquick DM 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Mefquick DM 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mefquick DM 80mg/250mg Tablet with a meal.
How Mefquick DM 80mg/250mg Tablet works:
Each Mefquick DM 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain- and inflammation-causing substances, reducing swelling and discomfort in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mefquick DM 80mg/250mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Mefquick DM 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mefquick DM 80mg/250mg tablets with breastfeeding are unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Mefquick DM 80mg/250mg Tablets, a potential side effect of this medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should use the 80mg/250mg Mefquick DM tablet cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in patients with severely compromised renal function.
LiverCAUTION
Patients with liver impairment should exercise caution when using Mefquick DM 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Mefquick DM 80mg/250mg Tablet :
Should you forget to take your Mefquick DM 80mg/250mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mefquick DM 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Digestive System |
3,018 People bought this recently